Cargando…
USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11
Mantle cell lymphoma (MCL) is an aggressive lymphoid malignancy with a poor prognosis. Ubiquitin-specific peptidase 9, X-linked (USP9X), has been associated with multiple physiological pathways and regulates various cellular activities. In this study, we explored the role of USP9X in MCL in vitro an...
Autores principales: | Huang, Gang, Liao, Jianjun, Wang, Mingli, Huang, Yali, Tang, Mingjie, Hao, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266782/ https://www.ncbi.nlm.nih.gov/pubmed/35865393 http://dx.doi.org/10.4084/MJHID.2022.048 |
Ejemplares similares
-
P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
por: Brown, F., et al.
Publicado: (2022) -
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma
por: Narurkar, Roshni, et al.
Publicado: (2016) -
Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis
por: Lee, Woojoo, et al.
Publicado: (2019) -
Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma
por: Masamha, Chioniso Patience, et al.
Publicado: (2016) -
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
por: Mohanty, Atish, et al.
Publicado: (2016)